NCT07590713

Brief Summary

This study evaluated whether eight weeks of Korean ginseng extract supplementation could affect exercise performance, body composition, and selected blood-based physiological markers in healthy adults. A total of 60 healthy adults aged 20 to 50 years were recruited and randomly assigned to either a Korean ginseng extract group or a placebo group in a double-blind, placebo-controlled design. Participants consumed one 10 mL packet of Korean ginseng extract or placebo daily for eight weeks. Assessments were performed before and after the intervention. Outcome measures included exercise performance tests, body composition, endocrine markers, inflammatory markers, oxidative stress markers, immune cell indices, and blood cell counts. Forty-nine participants completed the post-intervention assessments. The study was approved by the University of Taipei Institutional Review Board under approval number IRB-2023-011.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 9, 2024

Completed
2.1 years until next milestone

First Submitted

Initial submission to the registry

May 10, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 15, 2026

Completed
Last Updated

May 19, 2026

Status Verified

May 1, 2026

Enrollment Period

10 months

First QC Date

May 10, 2026

Last Update Submit

May 15, 2026

Conditions

Keywords

Korean ginseng extractGinseng supplementationFatigueBody composition

Outcome Measures

Primary Outcomes (1)

  • Change in Biceps Strength

    Change in biceps isokinetic strength from baseline to after eight weeks of supplementation, assessed using an isokinetic dynamometer.

    Baseline and 8 weeks

Secondary Outcomes (1)

  • Change in VO2max

    Baseline and 8 weeks

Study Arms (2)

Korean Ginseng Extract Group

EXPERIMENTAL

Participants received one 10 mL packet of Korean ginseng extract daily for eight weeks.

Dietary Supplement: Korean Ginseng Extract

Placebo Group

PLACEBO COMPARATOR

Participants received one 10 mL packet of placebo daily for eight weeks. The placebo was designed to have a similar taste and appearance to the Korean ginseng extract supplement.

Other: Placebo

Interventions

Korean Ginseng ExtractDIETARY_SUPPLEMENT

Korean ginseng extract supplement, provided as one 10 mL packet daily for eight weeks. The supplement contained ginseng extract, water, and fructooligosaccharides.

Korean Ginseng Extract Group
PlaceboOTHER

Placebo supplement, provided as one 10 mL packet daily for eight weeks. The placebo was designed to have a similar taste and appearance to the Korean ginseng extract supplement and contained water, maltodextrin, fructooligosaccharides, and casein phosphopeptide.

Placebo Group

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adults aged 20 to 50 years.
  • Able and willing to participate in the study.
  • Able to provide written informed consent.

You may not qualify if:

  • Allergy to ginseng products.
  • History of cardiovascular disease, asthma, diabetes, liver disease, kidney disease, arrhythmia, or other chronic diseases.
  • Current use of medications for chronic diseases.
  • Habitual use of ginseng or other traditional Chinese medicine-related supplements.
  • Pregnancy or breastfeeding.
  • Menopausal women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute of Sports Sciences, University of Taipei

Taipei, Taipei City, 111, Taiwan

Location

MeSH Terms

Conditions

ObesityOverweightMetabolic SyndromeFatigue

Interventions

Asian ginseng

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Participants and investigators were masked to group assignment. The placebo was designed to have a similar taste and appearance to the Korean ginseng extract supplement.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned in a 1:1 ratio to receive either Korean ginseng extract or placebo once daily for eight weeks.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 10, 2026

First Posted

May 15, 2026

Study Start

June 27, 2023

Primary Completion

April 9, 2024

Study Completion

April 9, 2024

Last Updated

May 19, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the informed consent form did not include a specific plan for sharing individual-level data with other researchers, and participant confidentiality will be protected.

Locations